Menu
GWAS Study

A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology.

Akbari P, Vuckovic D, Stefanucci L et al.

37596262 PubMed ID
GWAS Study Type
29675 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AP
Akbari P
VD
Vuckovic D
SL
Stefanucci L
JT
Jiang T
KK
Kundu K
KR
Kreuzhuber R
BE
Bao EL
CJ
Collins JH
DK
Downes K
GL
Grassi L
GJ
Guerrero JA
KS
Kaptoge S
KJ
Knight JC
MS
Meacham S
SJ
Sambrook J
SD
Seyres D
SO
Stegle O
VJ
Verboon JM
WK
Walter K
WN
Watkins NA
DJ
Danesh J
RD
Roberts DJ
DA
Di Angelantonio E
SV
Sankaran VG
FM
Frontini M
BS
Burgess S
KT
Kuijpers T
PJ
Peters JE
BA
Butterworth AS
OW
Ouwehand WH
SN
Soranzo N
AW
Astle WJ
Chapter II

Abstract

Summary of the research findings

Blood cells contain functionally important intracellular structures, such as granules, critical to immunity and thrombosis. Quantitative variation in these structures has not been subjected previously to large-scale genetic analysis. We perform genome-wide association studies of 63 flow-cytometry derived cellular phenotypes-including cell-type specific measures of granularity, nucleic acid content and reactivity-in 41,515 participants in the INTERVAL study. We identify 2172 distinct variant-trait associations, including associations near genes coding for proteins in organelles implicated in inflammatory and thrombotic diseases. By integrating with epigenetic data we show that many intracellular structures are likely to be determined in immature precursor cells. By integrating with proteomic data we identify the transcription factor FOG2 as an early regulator of platelet formation and α-granularity. Finally, we show that colocalisation of our associations with disease risk signals can suggest aetiological cell-types-variants in IL2RA and ITGA4 respectively mirror the known effects of daclizumab in multiple sclerosis and vedolizumab in inflammatory bowel disease.

29,675 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

29675
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.